SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹564 Cr | ₹60 Cr | ₹60 Cr | ₹3.61 Cr | ₹3.22 Cr |
What is the latest Contingent Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹564 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹3.61 Cr |
| Mar2022 | ₹3.22 Cr |
How is Contingent Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹564 Cr | 838.61 | |
| Mar2025 | ₹60 Cr | 0.00 | |
| Mar2024 | ₹60 Cr | 1,563.71 | |
| Mar2023 | ₹3.61 Cr | 12.11 | |
| Mar2022 | ₹3.22 Cr | - | |
Compare Contingent Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹3,501.3 Cr | -0.5% | 14.6% | 16.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -0.5% |
14.6% |
16.4% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses